Skip to content

Listen Now

Threat Status podcast: Is the Biden administration sabotaging Trump on Ukraine policy?

Advertisement

In this image from video provided by C-SPAN, Louis Milione, the U.S. Drug Enforcement Administration's deputy administrator, speaks during a hearing held by the House Energy and Commerce Subcommittee on Health in Washington on Dec. 2, 2021. Milione, the DEA’s second-in-command, quietly resigned in 2023, amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face of the opioid epidemic: Purdue Pharma. (C-SPAN via AP, File)

In this image from video provided by C-SPAN, Louis Milione, the U.S. Drug Enforcement Administration's deputy administrator, speaks during a hearing held by the House Energy and Commerce Subcommittee on Health in Washington on Dec. 2, 2021. Milione, the DEA’s second-in-command, quietly resigned in 2023, amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face of the opioid epidemic: Purdue Pharma. (C-SPAN via AP, File)

Featured Photo Galleries